Try our beta test site

Lenalidomide and Paclitaxel in Prostate Cancer

This study has been terminated.
(Terminated early due to slow accrual as Phase I dose escalation study.)
Celgene Corporation
Information provided by (Responsible Party):
M.D. Anderson Cancer Center Identifier:
First received: July 3, 2009
Last updated: October 25, 2016
Last verified: October 2016
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: December 2015
  Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)